斑马鱼的社会地位调节了对5-HT2C受体激动剂和对抗剂的行为反应
Larissa Nunes de Oliveira1,2, Nuno Felix Paiva Alves3,4, Marta Candeias Soares3,4,5
1Núcleo de Teoria e Pesquisa do Comportamento, Universidade Federal do Pará, Belém, Brazil.
Social neuroscience
|August 5, 2025
概括
社会地位影响斑马鱼的焦虑类行为. 向色胺5-HT2C受体可以调节这些反应,下属对激动剂敏感度增加.
科学领域:
- 神经科学是一个神经科学.
- 伦理学 伦理学 伦理学
- 行为药理学行为药理学
背景情况:
- 社会层次结构会影响物种间的行为和生理反应.
- 与主导个体相比,下属个体往往表现出高度的防御行为,表明类似焦虑的状态.
- 血清系统,特别是5-HT2受体,参与调节威胁反应和压力,包括由社会冲突引起的压力.
研究的目的:
- 研究血清素5-HT2C受体在调解与斑马鱼社会主导相关的焦虑类行为中的作用.
- 确定5-HT2C受体的药理学操纵如何影响在新型环境中主导和附属斑马鱼的行为.
主要方法:
- 148个成年斑马鱼在五天内被配对,建立了主导-附属关系.
- 动物接受了5-HT2C受体激动剂 (MK-212) 或对抗剂 (RS-102221) 的治疗.
- 使用新型坦克测试来评估行为,测量诸如底部居住,游泳模式和结等参数.
主要成果:
- 5-HT2C激动剂MK-212在所有斑马鱼中增加了类似焦虑的行为 (生活在底部,不规则的游泳,结),对下属有更明显的影响.
- 5-HT2C对手RS-102221在主导鱼类中减少了这些行为,但在下属鱼类中增加了它们.
- 这些发现表明,在下属斑马鱼中,5-HT2C受体具有潜在的敏感性.
结论:
- 社会地位显著调节斑马鱼的焦虑类行为.
- 5-HT2C受体在对社会层次和压力的行为反应中发挥着关键作用.
- 对5-HT2C受体的药理向为调节与社会压力相关的行为提供了潜在的途径,基于社会地位产生差异性影响.
相关概念视频
G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...


